SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026283
Filing Date
2021-05-11
Accepted
2021-05-11 07:20:40
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20210331.htm 10-Q 2019805
2 EX-31.1 imra-ex311_6.htm EX-31.1 20731
3 EX-31.2 imra-ex312_7.htm EX-31.2 20969
4 EX-32.1 imra-ex321_9.htm EX-32.1 9838
5 EX-32.2 imra-ex322_8.htm EX-32.2 10039
  Complete submission text file 0001564590-21-026283.txt   5891684

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imra-20210331.xml EX-101.INS 978437
7 XBRL TAXONOMY EXTENSION SCHEMA imra-20210331.xsd EX-101.SCH 44105
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20210331_cal.xml EX-101.CAL 43692
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20210331_def.xml EX-101.DEF 132824
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20210331_lab.xml EX-101.LAB 357851
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20210331_pre.xml EX-101.PRE 282738
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 21909603
SIC: 2834 Pharmaceutical Preparations